Preliminary Program: Saturday, May 19
8 a.m.-Noon
CME Courses 1-4
9 a.m.-4 p.m.
CME Courses 5-9
12:30 p.m.-3:30 p.m.
Industry-Supported Symposia
IS1. Clinical Management of ADHDSupported by Shire U.S. Inc.
Office-Based Diagnosis Keith McBurnett, Ph.D. | |||||
Treatment of ADHD in Special Groups Christopher J. Kratochvil, M.D. | |||||
Addressing Comorbidity in ADHD Paul G. Hammerness, M.D. | |||||
Effective Psychotherapies for Adults With ADHD Mary Solanto, Ph.D. | |||||
Managing ADHD in High-Risk Groups Timothy E. Wilens, M.D. | |||||
IS2. Expert Dialogue on Alzheimer's Disease: Diagnostic and Referral Issues, Treatment of the Cognitive Deficits, Ameliorating the Behavior Complications, and Comprehensive Multidisciplinary CareSupported by Forest Laboratories Inc.
Comprehensive Multidisciplinary Care for Patients With Alzheimer's Disease Warachal E. Faison, M.D. | |||||
The Expert Dialogue on Alzheimer's Disease: Diagnostic and Referral Issues, Treatment of Cognitive Deficits, Ameliorating the Behavioral Complications, and Comprehensive Multidisciplinary Care Pierre N. Tariot, M.D. | |||||
Behavioral Complications of Alzheimer's Disease Jacobo E. Mintzer, M.D. | |||||
To Be Announced William E. Reichman, M.D. | |||||
IS3. Recognition and Management of Restless Legs Syndrome (RLS) in Psychiatric Practice
To Be Announced B.A. Phillips, M.D. | |||||
RLS-Associated Psychiatric Symptoms H.B. Lee, M.D. | |||||
The Psychiatrist's Role in Managing RLS P.M. Becker, M.D. | |||||
Treatment Options for RLS J. Montplaisir, M.D. | |||||
1 p.m.-5 p.m.
CME Courses 10-13
6 p.m.-9 p.m.
Industry-Supported Symposia
IS4. Insights From STAR*D: Are Our Patients' Needs Being Met?Supported by Cyberonics, Cephalon, and Wyeth
Do Antidepressants Work in the Real World and for Whom? Roy H. Perlis, Ph.D. | |||||
Switching Antidepressants: The STAR*D Experience Michael E. Thase, M.D. | |||||
Polypharmacy to Increase the Chances of Achieving Remission Maurizio Fava, M.D. | |||||
Augmentation and Combination Strategies in Treatment-Resistant Depression Alan F. Schatzberg, M.D. | |||||
The Role of Psychotherapy as Adjunctive Treatment in Depression Amy H. Farabaugh, Ph.D. | |||||
IS5. Insomnia: Primary Diagnosis or Secondary Symptom?Supported by Merck and Co. Inc.
Clinical Cross Fire: Comorbid Insomnia Case Study Mugdha E. Thakur, M.D. | |||||
The State of Insomnia: Barriers to Recognition Ruth M. Benca, M.D. | |||||
To Be Announced Xavier A. Preud'Homme, M.D. | |||||
Pharmacological Understanding and Progress in Insomnia David J. Nutt, D.M. | |||||
IS6. Clinical Skills to Clinical Scales: Practical Tools in the Management of Patients With SchizophreniaSupported by Pfizer Inc.
Clinical Assessment of Medical Comorbidities Stephen R. Marder, M.D. | |||||
Clinical Management of the Acutely Psychotic Patient Michael H. Allen, M.D. | |||||
Measuring Cognitive and Functional Outcomes: Are the Scales Ready for Clinical Use? Rona Hu, M.D. | |||||
Combining Measurement Tools and Real-World Factors to Address the Needs of Patients With Schizophrenia John M. Kane, M.D. | |||||
IS7. The Prevailing Predominant Pole of Bipolar DepressionSupported by Glaxo-SmithKline
Neurobiology of Bipolar Depression: Implications for Treatment Robert M. Post, M.D. | |||||
New Treatment Options for Bipolar Depression Marcia L. Verduin, M.D. | |||||
Clinical Correlates Associated With Treatment-Emergent Mania Mark A. Frye, M.D. | |||||
The Clinical Interface Between Obesity and Bipolar Depression Susan L. McElroy, M.D. | |||||
The Clinical Challenges of Diagnosing and Treating Adolescents With Bipolar Depression Kiki D. Chang, M.D. | |||||
6:30 p.m.-8 p.m.
Lecture:Francisco Fernandez, M.D., APA's Simon Bolivar Award Lecture ▪
